InnovAge Reports Strong Q3 Results, Raises Full-Year Revenue and Adjusted EBITDA Guidance
summarizeSummary
InnovAge Holding Corp. announced strong fiscal third-quarter results with a 15.5% revenue increase and a significant rise in Adjusted EBITDA, leading to raised full-year guidance for both metrics.
check_boxKey Events
-
Strong Revenue Growth
Total revenues increased by 15.5% to $251.9 million for the fiscal third quarter ended March 31, 2026, compared to $218.1 million in the prior year.
-
Significant Adjusted EBITDA Improvement
Adjusted EBITDA surged to $30.5 million, a substantial increase from $10.8 million in the third quarter of fiscal year 2025, with the Adjusted EBITDA margin rising to 12.1% from 4.9%.
-
Raised Full-Year Guidance
The company raised its full-year fiscal 2026 guidance for total revenues to a range of $950 million to $975 million and Adjusted EBITDA to a range of $85 million to $90 million.
-
Increased Net Loss Due to Litigation
InnovAge reported a net loss of $29.9 million, or $0.22 per share, compared to a net loss of $11.1 million in the prior year, primarily driven by $51.9 million in litigation costs and settlements.
auto_awesomeAnalysis
InnovAge Holding Corp. delivered a robust fiscal third quarter, marked by significant revenue growth and a substantial increase in Adjusted EBITDA, which reflects strong operational performance. The company's decision to raise its full-year revenue and Adjusted EBITDA guidance signals management's confidence in continued positive momentum. While the GAAP net loss widened due to increased litigation costs and settlements, the underlying business health, as indicated by the Adjusted EBITDA and participant growth, appears strong. This update provides a positive outlook for investors, suggesting improved profitability and operational efficiency moving forward.
At the time of this filing, INNV was trading at $8.55 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $2.84 to $10.69. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.